Alex Sapir
2017
In 2017, Alex Sapir earned a total compensation of $6M as President and Chief Executive Officer at Dova Pharmaceuticals.
Compensation breakdown
| Bonus | $20,000 |
|---|---|
| Non-Equity Incentive Plan | $180,000 |
| Option Awards | $5,414,664 |
| Salary | $400,077 |
| Other | $2,002 |
| Total | $6,016,743 |
Sapir received $5.4M in option awards, accounting for 90% of the total pay in 2017.
Sapir also received $20K in bonus, $180K in non-equity incentive plan, $400.1K in salary and $2K in other compensation.
Rankings
In 2017, Alex Sapir's compensation ranked 1,458th out of 14,666 executives tracked by ExecPay. In other words, Sapir earned more than 90.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,458 out of 14,666 | 90th |
Division Manufacturing | 492 out of 5,772 | 92nd |
Major group Chemicals And Allied Products | 130 out of 2,075 | 94th |
Industry group Drugs | 93 out of 1,731 | 95th |
Industry Pharmaceutical Preparations | 72 out of 1,333 | 95th |
Source: SEC filing on April 27, 2018.
Sapir's colleagues
We found two more compensation records of executives who worked with Alex Sapir at Dova Pharmaceuticals in 2017.